Edition:
United States

Corvus Pharmaceuticals Inc (CRVS.OQ)

CRVS.OQ on NASDAQ Stock Exchange Global Market

8.86USD
21 Sep 2018
Change (% chg)

$-0.56 (-5.94%)
Prev Close
$9.42
Open
$9.31
Day's High
$9.38
Day's Low
$8.79
Volume
92,903
Avg. Vol
29,966
52-wk High
$17.08
52-wk Low
$7.45

Chart for

About

Corvus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of immuno-oncology therapies. The Company is developing drugs and antibodies that block crucial immune checkpoints and reprogram immune T-cells. The Company has a pipeline of four immuno-onc... (more)

Overall

Beta: --
Market Cap(Mil.): $258.69
Shares Outstanding(Mil.): 29.20
Dividend: --
Yield (%): --

Financials

  CRVS.OQ Industry Sector
P/E (TTM): -- 108.33 32.69
EPS (TTM): -2.23 -- --
ROI: -43.21 1.50 12.72
ROE: -43.57 0.19 14.85

BRIEF-Corvus Pharmaceuticals Q1 Loss Per Share $0.63

* CORVUS PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

May 03 2018

Earnings vs. Estimates